ENLV
Enlivex Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
ENLV fundamentals
Enlivex Therapeutics (ENLV) released its earnings on May 30, 2025: revenue was -- (YoY 0.00%), beat estimates; EPS was -0.15 (YoY +31.82%), met estimates.
Revenue / YoY
--
0.00%
EPS / YoY
-0.15
+31.82%
Report date
May 30, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Enlivex Therapeutics (ENLV) key financial stats and ratios, covering profitability, financial health, and leverage.
Enlivex Therapeutics (ENLV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Enlivex Therapeutics (ENLV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Enlivex Therapeutics (ENLV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Enlivex Therapeutics (ENLV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Enlivex Therapeutics (ENLV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Enlivex Therapeutics’s gross profit margin?What is the market’s earnings forecast for Enlivex Therapeutics next quarter?What is Enlivex Therapeutics’s latest dividend and current dividend yield?Did Enlivex Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Enlivex Therapeutics’s earnings call?What is the revenue and EPS growth rate for Enlivex Therapeutics year over year?How were Enlivex Therapeutics’s latest financial results overall?What factors drove the changes in Enlivex Therapeutics’s revenue and profit?